RFK Jr. Defends President Trump's Drug Price Claims Amid Criticism
Health and Human Services Secretary Robert F. Kennedy Jr. defended President Trump's controversial claims regarding prescription drug price reductions. During an Oval Office meeting, Kennedy attempted to rationalize Trump's assertion that drug prices could be reduced by percentages such as 1,000%, 600%, and 1,500%, which critics have pointed out are mathematically impossible. Kennedy's explanation involved a flawed interpretation of percentage calculations, suggesting that a price drop from $600 to $100 could be seen as a 600% savings, which is incorrect. This defense comes as the Trump administration promotes its efforts to lower drug prices, including a deal with biotech company Regeneron and the launch of the TrumpRx website, aimed at offering lower-cost drugs. 
